The Nasdaq Stock Market ended the session with Arena Pharmaceuticals jumping 2.43% to $75.21 on Tuesday while the Nasdaq Stock Market jumped 0.39% to $12,792.10.
Arena Pharmaceuticals today's close was $75.21, 19.92% below its 52-week high of $90.19.
Arena Pharmaceuticals's Sales
Arena Pharmaceuticals's sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company's growth estimates for the present quarter is a negative 4.5% and positive 4.5% for the next.
Arena Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals's Stock Yearly Top and Bottom Value
Arena Pharmaceuticals's stock is valued at $75.21 at 16:10 EST, way under its 52-week high of $90.19 and way above its 52-week low of $32.95.